The Food and Drug Administration limited the labeling of Egalet Corp.'s (Nasdaq: EGLT) newly approved long-acting opioid painkiller Arymo ER. The stock price tumbled $1.86 to close at $6.52.
FDA limits Egalet's Arymo ER label
January 10, 2017 at 16:20 PM EST
